On July 29, Trammell Crow Company broke ground on Fulton Labs, a laboratory facility that is being developed to help solve chronic lab space shortage throughout the Chicago region. Fulton Labs is located at 400 N. Aberdeen St., in the heart of the Fulton Market District, Chicago’s fastest growing neighborhood and one of the hottest tech markets in the country.
 
The 423,454-square-foot facility will span 16 floors, including 12 floors of advanced wet and dry lab space. The facility is designed to offer researchers the flexibility they need with features like column-free and long-span layouts and lab space that meets VC-A vibration criteria, which is important for researchers as they strive for reproducible results.
 
“Illinois is home to a massive biopharma concentration, one of the largest tech talent pools in the United States, and some of the best research universities on earth,” said governor JB Pritzker. “I’m committed to building an Illinois economy that creates jobs and expands access to prosperity – and the life science industry is a critical asset to that vision. Fulton Labs brings over 400,000 square feet of best-in-class lab facilities to Illinois, and I’m proud to welcome this expansion to our biotech ecosystem in this critical moment for innovation in the life sciences and healthcare.”
 
Fulton Labs is an example of the collaboration between the business and life science communities to invest and build a foundation to fuel growth in Illinois. It will nurture the scientific community and provide a home to drive innovation and discovery. To facilitate this, Trammell Crow Company has partnered with Portal Innovations, a life sciences start-up incubator founded by John Flavin, to dedicate space as a launchpad for early stage companies.
 
“Chicago and specifically Fulton Market, has the top-tier talent, academic institutions and infrastructure to be a premier life sciences hub” said John Flavin. “Portal Innovations will assemble these components and enable start-up companies to bridge scientific ideation and entrepreneurship to deliver breakthrough biomedical technologies and improve health and wellness.”